Correlation Between Bristol Myers and Applied Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Applied Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Applied Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and Applied Therapeutics, you can compare the effects of market volatilities on Bristol Myers and Applied Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Applied Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Applied Therapeutics.

Diversification Opportunities for Bristol Myers and Applied Therapeutics

0.15
  Correlation Coefficient

Average diversification

The 3 months correlation between Bristol and Applied is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Applied Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Applied Therapeutics and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Applied Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Applied Therapeutics has no effect on the direction of Bristol Myers i.e., Bristol Myers and Applied Therapeutics go up and down completely randomly.

Pair Corralation between Bristol Myers and Applied Therapeutics

Considering the 90-day investment horizon Bristol Myers Squibb is expected to generate 0.33 times more return on investment than Applied Therapeutics. However, Bristol Myers Squibb is 3.03 times less risky than Applied Therapeutics. It trades about -0.11 of its potential returns per unit of risk. Applied Therapeutics is currently generating about -0.05 per unit of risk. If you would invest  6,060  in Bristol Myers Squibb on November 27, 2024 and sell it today you would lose (272.00) from holding Bristol Myers Squibb or give up 4.49% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Bristol Myers Squibb  vs.  Applied Therapeutics

 Performance 
       Timeline  
Bristol Myers Squibb 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Bristol Myers Squibb has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong primary indicators, Bristol Myers is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Applied Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Applied Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Bristol Myers and Applied Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bristol Myers and Applied Therapeutics

The main advantage of trading using opposite Bristol Myers and Applied Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Applied Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Applied Therapeutics will offset losses from the drop in Applied Therapeutics' long position.
The idea behind Bristol Myers Squibb and Applied Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated